Prelude Capital Management, LLC Tandem Diabetes Care Inc Transaction History

Prelude Capital Management, LLC

$1.39 Billion
Q2 2024

A detailed history of Prelude Capital Management, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 37,921 shares of TNDM stock, worth $1.61 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

37,921

Previous 76,030 50.12%

Holding current value

$1.61 Million

Previous $2.69 Million 43.28%

% of portfolio

0.11%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$30.43 - $53.43 $1.16 Million - $2.04 Million	-38,109 Reduced 50.12%	37,921 $1.53 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $1.5 Million - $2.41 Million	68,105 Added 859.37%	76,030 $2.69 Million
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $113,169 - $245,912	7,925 New	7,925 $234,000
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $113,281 - $146,893	-3,159 Reduced 32.66%	6,514 $264,000
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $196,756 - $311,295	-5,544 Reduced 36.43%	9,673 $434,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $266,104 - $419,406	6,081 Added 66.56%	15,217 $728,000
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $377,915 - $874,062	-7,101 Reduced 43.73%	9,136 $541,000
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $1.26 Million - $1.86 Million	12,392 Added 322.29%	16,237 $1.89 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $38,526 - $49,946	326 Added 9.26%	3,845 $579,000
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $722,458 - $999,744	-7,726 Reduced 68.71%	3,519 $420,000
Q2 2021 Aug 16, 2021	BUY	$77.0 - $100.19 $865,865 - $1.13 Million	11,245 New	11,245 $1.1 Million
Q3 2020 Nov 16, 2020	SELL	$95.43 - $116.09 $98,388 - $119,688	-1,031 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.05 - $98.92 $61,911 - $101,986	1,031 New	1,031 $102,000
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $222,449 - $422,827	-4,696 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.13 - $71.19 $239,191 - $320,497	4,502 Added 2320.62%	4,696 $280,000
Q3 2019 Nov 14, 2019	BUY	$57.11 - $73.3 $4,683 - $6,010	82 Added 73.21%	194 $11,000
Q2 2019 Aug 14, 2019	SELL	$54.41 - $71.7 $595,136 - $784,254	-10,938 Reduced 98.99%	112 $7,000
Q1 2019 May 15, 2019	SELL	$32.25 - $73.56 $207,109 - $472,402	-6,422 Reduced 36.76%	11,050 $702,000
Q4 2018 Feb 14, 2019	BUY	$28.45 - $40.65 $466,323 - $666,294	16,391 Added 1516.28%	17,472 $663,000
Q3 2018 Nov 14, 2018	SELL	$21.39 - $51.17 $29,732 - $71,126	-1,390 Reduced 56.25%	1,081 $46,000
Q2 2018 Aug 14, 2018	SELL	$4.9 - $23.64 $31,208 - $150,563	-6,369 Reduced 72.05%	2,471 $54,000
Q1 2018 May 15, 2018	BUY	$2.35 - $4.96 $20,687 - $43,662	8,803 Added 23791.89%	8,840 $44,000
Q4 2017 Feb 14, 2018	BUY	$2.24 - $8.2 $82 - $303	37	37 $0

Others Institutions Holding TNDM

# of Institutions

344

Shares Held

72.7M

Call Options Held

3.12M

Put Options Held

343K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.73B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Tandem Diabetes Care Inc Transaction History